High Point Advisor Group LLC Moderna, Inc. Transaction History
High Point Advisor Group LLC
- $1.76 Billion
- Q2 2024
A detailed history of High Point Advisor Group LLC transactions in Moderna, Inc. stock. As of the latest transaction made, High Point Advisor Group LLC holds 4,223 shares of MRNA stock, worth $277,662. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,223
Previous 3,454
22.26%
Holding current value
$277,662
Previous $368,000
36.14%
% of portfolio
0.03%
Previous 0.03%
Shares
10 transactions
Others Institutions Holding MRNA
# of Institutions
1,113Shares Held
241MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO43.4MShares$2.86 Billion4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.6 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.68 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$988 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$475 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $25.7B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...